| Biomaterials‐based approaches to tumor spheroid and organoid modeling PS Thakuri, C Liu, GD Luker, H Tavana Advanced healthcare materials 7 (6), 1700980, 2018 | 130 | 2018 |
| Liquid-based three-dimensional tumor models for cancer research and drug discovery SL Ham, R Joshi, PS Thakuri, H Tavana Experimental biology and medicine 241 (9), 939-954, 2016 | 110 | 2016 |
| Three-dimensional tumor model mimics stromal–breast cancer cells signaling SL Ham, PS Thakuri, M Plaster, J Li, KE Luker, GD Luker, H Tavana Oncotarget 9 (1), 249, 2018 | 60 | 2018 |
| Quantitative size-based analysis of tumor spheroids and responses to therapeutics PS Thakuri, M Gupta, M Plaster, H Tavana ASSAY and Drug Development Technologies 17 (3), 140-149, 2019 | 53 | 2019 |
| Multiparametric analysis of oncology drug screening with aqueous two-phase tumor spheroids P Shahi Thakuri, SL Ham, GD Luker, H Tavana Molecular pharmaceutics 13 (11), 3724-3735, 2016 | 52 | 2016 |
| Antibacterial photodynamic therapy on Staphylococcus aureus and Pseudomonas aeruginosa in-vitro PS Thakuri, R Joshi, S Basnet, S Pandey, SD Taujale, N Mishra Nepal Med. Coll. J 13 (4), 281-284, 2011 | 51 | 2011 |
| Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling P Shahi Thakuri, M Gupta, S Singh, R Joshi, E Glasgow, A Lekan, ... BMC cancer 20, 1-14, 2020 | 47 | 2020 |
| Organotypic breast tumor model elucidates dynamic remodeling of tumor microenvironment S Singh, LA Ray, PS Thakuri, S Tran, MC Konopka, GD Luker, H Tavana Biomaterials 238, 119853, 2020 | 31 | 2020 |
| Cyclical treatment of colorectal tumor spheroids induces resistance to MEK inhibitors PS Thakuri, GD Luker, H Tavana Translational Oncology 12 (3), 404-416, 2019 | 24 | 2019 |
| Single and combination drug screening with aqueous biphasic tumor spheroids P Shahi Thakuri, H Tavana SLAS DISCOVERY: Advancing Life Sciences R&D 22 (5), 507-515, 2017 | 20 | 2017 |
| Microprinted stem cell niches reveal compounding effect of colony size on stromal cells‐mediated neural differentiation R Joshi, PS Thakuri, JC Buchanan, J Li, H Tavana Advanced healthcare materials 7 (5), 1700832, 2018 | 18 | 2018 |
| Synergistic inhibition of kinase pathways overcomes resistance of colorectal cancer spheroids to cyclic targeted therapies PS Thakuri, M Gupta, R Joshi, S Singh, H Tavana ACS pharmacology & translational science 2 (4), 275-284, 2019 | 16 | 2019 |
| Therapeutic targeting of cancer stem cells prevents resistance of colorectal cancer cells to MEK inhibition A Lamichhane, P Shahi Thakuri, S Singh, P Rafsanjani Nejad, J Heiss, ... ACS Pharmacology & Translational Science 5 (9), 724-734, 2022 | 9 | 2022 |
| Modeling adaptive resistance of KRAS mutant colorectal cancer to MAPK pathway inhibitors with a three-dimensional tumor model P Shahi Thakuri, A Lamichhane, S Singh, M Gupta, GD Luker, H Tavana ACS Pharmacology & Translational Science 3 (6), 1176-1187, 2020 | 9 | 2020 |
| Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroids A Lamichhane, PS Thakuri, P Rafsanjani Nejad, H Tavana Experimental Biology and Medicine 246 (22), 2372-2380, 2021 | 6 | 2021 |
| Microprinted tumor spheroids enable anti-cancer drug screening PS Thakuri, SL Ham, H Tavana 2016 38th Annual International Conference of the IEEE Engineering in …, 2016 | 5 | 2016 |
| Toxicity of combinations of kinase pathway inhibitors to normal human cells in a three-dimensional culture P Rafsanjani Nejad, P Shahi Thakuri, S Singh, A Lamichhane, J Heiss, ... SLAS TECHNOLOGY: Translating Life Sciences Innovation 26 (3), 255-264, 2021 | 4 | 2021 |
| Robotic printing and drug testing of 384-well tumor spheroids SL Ham, PS Thakuri, H Tavana 2015 37th Annual International Conference of the IEEE Engineering in …, 2015 | 4 | 2015 |
| Establishment of hormone-dependent endometrial tumoroids in a conditioned-medium free, serum-free medium C Yankaskas, B Balhouse, C Paul, PS Thakuri, S Salen, M Kennedy, ... Cancer Research 84 (6_Supplement), 4251-4251, 2024 | | 2024 |
| Rapid and robust generation of ex vivo tumoroid samples from fresh patient samples in a serum-free, conditioned medium-free system C Paul, A Bullock, A Chatman, B Balhouse, C Yankaskas, PS Thakuri, ... Cancer Research 84 (6_Supplement), 4233-4233, 2024 | | 2024 |
Hossein TavanaThe University of Akron在 uakron.edu 的电子邮件经过验证
